Medical Condition News

RSS

Alemtuzumab as effective as other more expensive immune suppressants for kidney transplants

In the first head-to-head comparison of the three most common drugs used at the time of a kidney transplant to prevent organ rejection, researchers found that the least expensive drug - at one-half to one-fifth the price - is as safe and effective as the other two, according to a paper published by University of Alabama at Birmingham researchers in the May 19, 2011, issue of the New England Journal of Medicine.

19 May 2011

Study suggests link between obesity, psoriasis and heart disease risk in children

Children who are overweight or obese have a significantly higher prevalence of psoriasis, and teens with psoriasis, regardless of their body weight, have higher cholesterol levels, according to a Kaiser Permanente study published online in the Journal of Pediatrics.

19 May 2011

Goat milk has nutritional characteristics beneficial to human health

Researchers at the University of Granada have found that goat milk has nutritional characteristics beneficial to health. They have determined that goat milk has many nutrients that make it similar to human milk.

19 May 2011

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.

19 May 2011

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.

19 May 2011

Heavy alcohol consumption linked to increased risk of gastric cancer

The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer - that is - that the risk may be real for heavy alcohol consumption but not for moderate intake.

19 May 2011

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Abbott announced today that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), the leading cause of liver cancer in the United States.

19 May 2011

Estradiol may exacerbate tumor growth in breast cancer

A recently discovered enzyme drives the production of a potent form of estrogen in human breast cancer tissue, researchers from the University of Illinois at Chicago College of Medicine have found.

19 May 2011

Mayo Clinic develops new screening procedure for Lynch syndrome detection

Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.

19 May 2011

'Gatekeeper' protein plays a key role in skin-cancer prevention

New research from North Carolina State University shows that a "gatekeeper" protein plays an important role in skin-cancer prevention in humans and lab mice.

19 May 2011

Mpex, Synteract partner for cystic fibrosis fundraising event

Synteract, Inc., a full-service, global contract research organization, and Mpex Pharmaceuticals, a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, have partnered for the second annual Great Strides fundraiser to benefit cystic fibrosis.

19 May 2011

Biothera begins dosing in Imprime PGG and cetuximab combination Phase III trial for colorectal cancer

Biothera began dosing patients today in a Phase III trial evaluating Imprime PGG in combination with cetuximab as a potential new treatment for recurrent or progressive KRAS wild-type colorectal cancer.

19 May 2011

Fragile X syndrome may be treatable

Advancements over the last 10 years in understanding intellectual disability (ID, formerly mental retardation), have led to the once-unimaginable possibility that ID may be treatable, a review of more than 100 studies on the topic has concluded. It appears in ACS Chemical Neuroscience.

18 May 2011

New image-processing software allows significant radiation dose reduction

A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.

18 May 2011

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

18 May 2011

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold, are more common in older children and adults.

From Quest Diagnostics 18 May 2011

Scientists nail mechanism causing embryonic stem cells to differentiate into specialised cells

A team led by developmental biologist Professor Christophe Marcelle has nailed the mechanism that causes stem cells in the embryo to differentiate into specialised cells that form the skeletal muscles of animals' bodies.

18 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

Oak Point students raise $42,474.24 to combat cancer

Penny by penny, students at Oak Point Intermediate School in Eden Prairie, MN, raised an incredible $42,474.24 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs.

18 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

Medical Condition News

Alemtuzumab as effective as other more expensive immune suppressants for kidney transplants

Study suggests link between obesity, psoriasis and heart disease risk in children

Goat milk has nutritional characteristics beneficial to human health

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Heavy alcohol consumption linked to increased risk of gastric cancer

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Estradiol may exacerbate tumor growth in breast cancer

Mayo Clinic develops new screening procedure for Lynch syndrome detection

'Gatekeeper' protein plays a key role in skin-cancer prevention

Mpex, Synteract partner for cystic fibrosis fundraising event

Biothera begins dosing in Imprime PGG and cetuximab combination Phase III trial for colorectal cancer

Fragile X syndrome may be treatable

New image-processing software allows significant radiation dose reduction

InvoTek introduces new Safe Laser System for persons with limited movement

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Scientists nail mechanism causing embryonic stem cells to differentiate into specialised cells

Synergy expands GC-C agonist technology to lower cholesterol

Oak Point students raise $42,474.24 to combat cancer

Improved tissue grafts promote vascular growth in wound sites

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News